# STAG Industrial, Inc.: financial statements, quarterly

STAG · NYSE · CIK 1479094 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stag.md) · [Financials](/companies/stag/financials.md) · [Filings](/companies/stag/filings.md) · [Insiders](/companies/stag/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/stag/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [183 d](/filings/0001479094-26-000009.md) | [188](/filings/0001479094-25-000011.md) | [190](/filings/0001479094-25-000017.md) | [191](/filings/0001479094-25-000028.md) | [199 d](/filings/0001479094-26-000009.md) | [206](/filings/0001479094-26-000017.md) | [208](/filings/0001479094-26-000026.md) | [211](/filings/0001479094-26-000033.md) | [221 d](/filings/0001479094-26-000009.md) | [224](/filings/0001479094-26-000017.md) | [224](/filings/0001479094-26-000026.md) | [231](/filings/0001479094-26-000033.md) |
| Interest expense | $m | [25.4 d](/filings/0001479094-25-000006.md) | [25.4](/filings/0001479094-25-000011.md) | [27.4](/filings/0001479094-25-000017.md) | [28.7](/filings/0001479094-24-000031.md) | [31.7 d](/filings/0001479094-25-000006.md) | [32.5](/filings/0001479094-25-000011.md) | [33.6](/filings/0001479094-25-000017.md) | [31.7](/filings/0001479094-26-000033.md) | [34.3 d](/filings/0001479094-26-000009.md) | [35.9](/filings/0001479094-26-000017.md) | [37.5](/filings/0001479094-26-000026.md) | [39.1](/filings/0001479094-26-000033.md) |
| Net income | $m | [41.7 d](/filings/0001479094-26-000009.md) | [36.6](/filings/0001479094-25-000011.md) | [59.8](/filings/0001479094-25-000017.md) | [41.9](/filings/0001479094-25-000028.md) | [51.0 d](/filings/0001479094-26-000009.md) | [91.4](/filings/0001479094-26-000017.md) | [50.0](/filings/0001479094-26-000026.md) | [48.6](/filings/0001479094-26-000033.md) | [83.5 d](/filings/0001479094-26-000009.md) | [62.0](/filings/0001479094-26-000017.md) | [52.9](/filings/0001479094-26-000026.md) | [70.7](/filings/0001479094-26-000033.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.7](/filings/0001479094-25-000006.md) | [12.4](/filings/0001479094-24-000016.md) | [33.3](/filings/0001479094-24-000025.md) | [70.0](/filings/0001479094-24-000031.md) | [36.3](/filings/0001479094-26-000009.md) | [9.3](/filings/0001479094-25-000011.md) | [15.4](/filings/0001479094-25-000017.md) | [17.3](/filings/0001479094-25-000028.md) | [14.9](/filings/0001479094-26-000033.md) | [8.9](/filings/0001479094-26-000017.md) | [65.9](/filings/0001479094-26-000026.md) | [12.2](/filings/0001479094-26-000033.md) |
| Total assets | $m | [6,283](/filings/0001479094-25-000006.md) | [6,294](/filings/0001479094-24-000016.md) | [6,444](/filings/0001479094-24-000025.md) | [6,566](/filings/0001479094-24-000031.md) | [6,833](/filings/0001479094-26-000009.md) | [6,848](/filings/0001479094-25-000011.md) | [6,825](/filings/0001479094-25-000017.md) | [6,897](/filings/0001479094-25-000028.md) | [7,208](/filings/0001479094-26-000033.md) | [7,184](/filings/0001479094-26-000017.md) | [7,477](/filings/0001479094-26-000026.md) | [7,504](/filings/0001479094-26-000033.md) |
| Total liabilities | $m | [2,838](/filings/0001479094-25-000006.md) | [2,871](/filings/0001479094-24-000016.md) | [3,029](/filings/0001479094-24-000025.md) | [3,202](/filings/0001479094-24-000031.md) | [3,304](/filings/0001479094-26-000009.md) | [3,304](/filings/0001479094-25-000011.md) | [3,304](/filings/0001479094-25-000017.md) | [3,397](/filings/0001479094-25-000028.md) | [3,537](/filings/0001479094-26-000033.md) | [3,519](/filings/0001479094-26-000017.md) | [3,768](/filings/0001479094-26-000026.md) | [3,776](/filings/0001479094-26-000033.md) |
| Long-term debt | $m | [2,624](/filings/0001479094-25-000006.md) | [2,656](/filings/0001479094-24-000016.md) | [2,796](/filings/0001479094-24-000025.md) | [2,926](/filings/0001479094-24-000031.md) | [3,029](/filings/0001479094-26-000009.md) | [3,033](/filings/0001479094-25-000011.md) | [3,044](/filings/0001479094-25-000017.md) | [3,102](/filings/0001479094-25-000028.md) | [3,266](/filings/0001479094-26-000033.md) | [3,204](/filings/0001479094-26-000017.md) | [3,453](/filings/0001479094-26-000026.md) | [3,417](/filings/0001479094-26-000033.md) |
| Shareholders' equity | $m | [3,375](/filings/0001479094-25-000006.md) | [3,352](/filings/0001479094-24-000016.md) | [3,344](/filings/0001479094-24-000025.md) | [3,296](/filings/0001479094-24-000031.md) | [3,458](/filings/0001479094-26-000009.md) | [3,467](/filings/0001479094-25-000011.md) | [3,445](/filings/0001479094-25-000017.md) | [3,425](/filings/0001479094-25-000028.md) | [3,596](/filings/0001479094-26-000033.md) | [3,586](/filings/0001479094-26-000017.md) | [3,631](/filings/0001479094-26-000026.md) | [3,650](/filings/0001479094-26-000033.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [91.6 d](/filings/0001479094-26-000009.md) | [105](/filings/0001479094-25-000011.md) | [122 d](/filings/0001479094-25-000017.md) | [128 d](/filings/0001479094-25-000028.md) | [105 d](/filings/0001479094-26-000009.md) | [104](/filings/0001479094-26-000017.md) | [112 d](/filings/0001479094-26-000026.md) | [144 d](/filings/0001479094-26-000033.md) | [104 d](/filings/0001479094-26-000009.md) | [117](/filings/0001479094-26-000017.md) | [111 d](/filings/0001479094-26-000026.md) | [147 d](/filings/0001479094-26-000033.md) |
| Dividends paid | $m | [68.2 d](/filings/0001479094-26-000009.md) | [68.7](/filings/0001479094-25-000011.md) | [68.9 d](/filings/0001479094-25-000017.md) | [68.5 d](/filings/0001479094-25-000028.md) | [68.8 d](/filings/0001479094-26-000009.md) | [71.0](/filings/0001479094-26-000017.md) | [71.0 d](/filings/0001479094-26-000026.md) | [71.0 d](/filings/0001479094-26-000033.md) | [71.0 d](/filings/0001479094-26-000009.md) | [24.3](/filings/0001479094-26-000017.md) | [75.8 d](/filings/0001479094-26-000026.md) | [76.3 d](/filings/0001479094-26-000033.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [179](/filings/0001479094-24-000016.md) | [180](/filings/0001479094-24-000025.md) | [181](/filings/0001479094-24-000031.md) | [182](/filings/0001479094-25-000011.md) | [182](/filings/0001479094-25-000017.md) | [182](/filings/0001479094-25-000028.md) | [187](/filings/0001479094-26-000017.md) | [187](/filings/0001479094-26-000026.md) | [187](/filings/0001479094-26-000033.md) | [191](/filings/0001479094-26-000017.md) | [191](/filings/0001479094-26-000026.md) | [193](/filings/0001479094-26-000033.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 192,821,995 at 2026-10-26, from the cover of the [10-Q filed 2026-10-27](/filings/0001479094-26-000033.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 17:49 ET. No prices; not investment advice.